Harver Group Investing Heavily In Potential Cancer Cure
Jul. 22, 2013 - CHUO-KU, Japan -- Harvard Bioscience Inc. (HBIO) has received little attention for their research from the medical establishment or from educational institutions. While posting consistent growth and a strong customer base, shareholders have not seen much profit to date due to operating losses from the company´s Regenerative Medical Device division also known as Harvard Apparatus Regenerative Technology.
“We believe that Harvard Bioscience Inc. is a solid investment now” said Peter Anderson Senior Vice President of Mergers and Acquisitions at Harver Group, “before Harvard Apparatus Regenerative Technology is given an initial public offering”.
Head of Investment Analysis, Mr. Nathan Marx said “Removing Harvard Apparatus from their balance sheets should lead to an increase in valuation of at least 50% in the short term and potentially 100% in the long term if shareholder friendly policies are enacted. We expect the IPO to happen within four months”.
Harvard Apparatus Regenerative Technology is pursing ground breaking research; they are preforming clinical trials of their cure for trachea cancer. The trials have produced very exciting results, with a high survival rate for a typically fatal form of cancer. They’ve created scaffolding, which in conjunction with cells from the patient construct a new trachea. This technology has further applications, for lung and heart, heart valve, liver, and kidney transplants as well as esophageal cancer.
Both the President and CFO of Harvard Bioscience Inc. will be leaving to run Harvard Apparatus Regenerative Technology. We believe that this indicates that a sale of Harvard Bioscience is in the works, due to the fact that the President and CFO along with other members of management own 14% of the company. Management will likely maximize value, and sell the company for at least $10 a share. We are recommending our clients to move on Harvard Bioscience Inc. as soon as possible and we will bring more news on Harvard Apparatus Research Technology IPO as we receive it.
Harver Group help in the development of remarkable companies who have the need for a well connected and placed partner to help when the need arises for financial assistance by a team with management and strategic business acumen.
Nihonbashi Mitsui Tower, 26th Floor, 1-1, 2 Nihombashi-Muromachi
Chuo-ku, Tokyo, Japan 103-0022
Tel: +81 3 4578 1728
Fax:: +81 3 4333 7348
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Harver Group Investing Heavily In Potential Cancer Cure here
News-ID: 269436 • Views: 1701
More Releases from Harver Group
Banking Sector Roundup July 30th 2013 – A Difficult Day For A Number Of Banks
JP Morgan, Barclays, and Deutsche Bank are all having legal troubles. A JP Morgan division is accused of manipulating electricity markets, Barclays of not disclosing fees paid, and Deutsche Bank has a number of charges levied against it. Jul. 31, 2013 - CHUO-KU, Japan -- Major banks across the global are having legal and financial difficulties including; JP Morgan, Barclays, and Deutsche Bank. A division of JP Morgan Chase & Co.
Harver Group Appoints Senior Analyst Steven Vaughan
Experienced Trader to replace Senior Analyst at Harver Group. Jul. 18, 2013 - CHUO-KU, Japan -- Today Director and Co-founder at Harver Group Koji Masuto, announced that Steven Vaughan will be taking over as Senior Analyst. Mr. Vaughan will be replacing Michael Jones, who is retiring at the end of the year after 7 years of loyal service to Harver Group. “Michael Jones has performed an indispensable role during what has
European Markets Overview – 29th July 2013
Analysts at equity researcher Harver Group report advertising firms were some of the biggest gainers on Monday while Barclays and Ryan air share prices declined significantly. Jul. 30, 2013 - CHUO-KU, Japan -- The Stoxx Europe 600 index climbed half a point to 300.2, after a 0.2% dip on Friday. We expect the markets to remain fairly stagnant until later this week, as investor monitor meetings of The European Central Bank,
Harver Group Market Watch: Asia 26-07-13
The Asian markets were largely stagnate Thursday despite stimulus measures being unveiled in Beijing. Mining and Metal stocks were down as were major Japanese camera manufactures. The Chinese railway sector posted small gains. Jul. 26, 2013 - CHUO-KU, Japan -- Asian Markets faltered slightly Thursday; South Korea´s Kospi stock average dropped 0.1%, Japan´s Nikkei lost 1.1%, while Australia´s S&P/ASX 200 had a negligible gain. The situation in China and Hong Kong
More Releases for Harvard
Laboratory Ventilators Market to Witness Strong Growth by 2028 | Harvard, Appara …
Laboratory Ventilators Market research report provides extensive market coverage that includes qualitative and quantitative analysis of the overall market, its segments, and regional analysis. It sheds light on market growth drivers to understand the business's financial and operational output to improvise the company's performance and strategies. Furthermore, the report also incorporates challenges and opportunities that enable stakeholders to develop a strategic and precise business plan. Click Here For Free Sample +
HARVARD STUDENT FINDS MEANING IN SOCCER
FOR IMMEDIATE RELEASE Contact: Elana Khoury Phone: 502-759-9497 Email: firstname.lastname@example.org HARVARD STUDENT FINDS MEANING IN SOCCER After moving to Cambridge for school Jacob Khan found meaning in teaching kids’ soccer [Cambridge, Massachusetts, June 6/15/2020—] After moving to Cambridge MA from Louisville, KY, Jacob Khan attended his first Job Fair as a Harvard student. At the Student Employment Office fall job fair, Jacob met two coaches from Super Soccer Stars. Two weeks after the initial
Harvard Business School (HBS) Online & ASM expand relationship
Harvard Business School (HBS) Online & ASM expand relationship First & only b-school collaboration in India allows access to many HBS Online courses Mumbai, April 3rd, 2019: Harvard Business School (HBS) Online & Audyogik Shikshan Mandal (ASM), today expanded their current relationship covering only the business fundamentals to include nearly all courses offered on its’ online asynchronous platform. ASM is the only b-school in India that will offer a curriculum integrated
Harvard + Vienna = Economics at International Top
Harvard, Hong Kong, Berlin: Economist with excellent international connections accepts post at MODUL University Vienna The new head of the Department of International Management will begin researching and teaching immediately at Austria's leading private English-language business university The internationally active economist Professor Horst Treiblmaier has been appointed the new head of the Department of International Management at MODUL University Vienna. After holding academic posts in several countries, including at the University
XCOM Africa invited to Harvard Business School
Boston/Willich, 18.02.2013 XCOM Africa was recently invited to participate as one of a few selected panelists at the 15th Africa Business Conference, organized by the Harvard Business School in Boston, MA. The conference aimed to showcase those who continue to shape and influence the African story through business and enterprises, and to create an environment for like-minded individuals to meet, exchange ideas and spur one another on to action.
Protochips to Lead Poseidon™ Seminar at Harvard University
Protochips (http://www.protochips.com), a company specializing in revolutionary products for in situ electron microscopy, today announced a seminar to be held at Harvard University’s Wyss Institute for Biologically Inspired Engineering titled: Studying Hydrated Specimens In Situ Using Electron Microscopy. This seminar is open worldwide regardless of affiliation. Conventional sample processing techniques, such as staining, drying, sectioning, or freezing often introduce preparation artifacts that obscure the interpretation of electron micrographs. With